Abstract | BACKGROUND: Only limited data has been reported so far regarding oesophageal cancer (EC) in elderly patients. The aim of the study is to identify the baseline parameters that influenced therapeutic decision. METHODS: RESULTS: Two hundred and eighty-two patients were studied. Mean age was 76.5 ± 5.5 years and 22.4% of patients had visceral metastasis. In patients without visceral metastasis (n = 220) the majority had treatment with curative intent (n = 151) whereas in patients with metastasis (n = 62) the majority had BSC (n = 32). Severe adverse events (≥ grade 3) were observed in only 17% of the patients. Patients without specific carcinologic treatment were older, had more weight loss, worse WHO performance status and Charlson score in multivariate analysis. DISCUSSION: Our results suggest that elderly patients with an EC could benefit from cancer treatment without major toxicities. Weight loss, WHO performance status and the Charlson score could be used to select the appropriate treatment in an elderly patient.
|
Authors | David Tougeron, Hadji Hamidou, Michel Scotté, Frédéric Di Fiore, Michel Antonietti, Bernard Paillot, Pierre Michel |
Journal | BMC cancer
(BMC Cancer)
Vol. 10
Pg. 510
(Sep 24 2010)
ISSN: 1471-2407 [Electronic] England |
PMID | 20868479
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(adverse effects)
- Esophageal Neoplasms
(epidemiology, therapy)
- Female
- Geriatrics
(methods)
- Humans
- Male
- Medical Oncology
(methods)
- Middle Aged
- Models, Statistical
- Neoplasm Metastasis
- Palliative Care
- Retrospective Studies
- Treatment Outcome
|